Brazil vs Japan: Avoidable mortality
Avoidable mortality over time
- Brazil
- Japan
How they compare
Brazil currently reports 608,011 Deaths against 213,167 Deaths in Japan, a difference of 394,844 Deaths.
That makes Brazil's figure about 2.9 times Japan's.
Across all 24 years both countries report, Brazil has been ahead every year.
Brazil ranks 2nd and Japan ranks 5th of 36 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 483,011 Deaths | 291,384 Deaths | 191,627 Deaths | Brazil |
| 2010s | 557,051 Deaths | 244,021 Deaths | 313,031 Deaths | Brazil |
| 2020s | 705,252 Deaths | 216,212 Deaths | 489,041 Deaths | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher avoidable mortality, Brazil or Japan?
- Brazil, at 608,011 Deaths against 213,167 Deaths in Japan as of 2023.
- What is the difference in avoidable mortality between Brazil and Japan?
- 394,844 Deaths, with Brazil ahead.
- How many years of comparable data are there for Brazil and Japan?
- 24 years are reported by both, from 2000 to 2023.
- How do Brazil and Japan rank globally for avoidable mortality?
- Brazil ranks 2nd and Japan ranks 5th of 36 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Avoidable mortality. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents data on preventable, treatable and avoidable (preventable + treatable) causes of mortality. Preventable and treatable causes of mortality are defined as follows: - Preventable mortality: Causes of death that can be mainly avoided through effective public health and primary prevention interventions (i.e. before the onset of diseases/injuries, to reduce incidence). - Treatable (or amenable) mortality: Causes of death that can be mainly avoided through timely and effective healthcare interventions, including secondary prevention such as screening, and treatment (i.e. after the onset of diseases, to reduce case-fatality). Both indicators refer to premature mortality (under age 75). Please refer to the Sources and Methods for detailed country-specific information.